Biotech News

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Share

Ensign Group (ENSG)Ensign GroupCompany update

The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before January 31, 2026, to shareholders of record as of December 31, 2025. “We are proud to announce our twenty-third consecutive annual dividend increase, which is a reflection on our strong market position and commitment to return value to our shareholders,” commented Barry Port, Ensign's Chief Executive Officer. “We are excited for the upcoming year and what it will bring for our organization and shareholders,” he added.

Ensign has been a dividend-paying company since 2002.

About Ensign ™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 373 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net .

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

Related news

Ensign Group

Post-Acute Care Operating Platform The Ensign Group operates skilled nursing, senior living, rehabilitation, and other post-acute care services through independent subsidiaries across multiple U.S. states. Performance depends on decentralized local management, facility quality, and reimbursement conditions across government and...

Recent company news

Stock data

Close
179.48 USD
Market cap
9.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States